NCT03774446
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
Clinical trial condition
Pituitary ACTH Hypersecretion
Explore clinical trials studying Pituitary ACTH Hypersecretion. Study availability and eligibility vary by location and protocol.
47 public trials
12 recruiting studies
Pituitary ACTH Hypersecretion trial results
NCT06962202
- Conditions
- Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +8 more
- Locations
-
- Post Graduate Institute of Medical Sciences Chandigarh, India
Not yet recruiting
PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours
NCT07813351
- Conditions
- Acromegaly, Acromegaly Due to Pituitary Adenoma, Adenoma, +25 more
- Locations
-
Not specified
Not yet recruiting
Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection
NCT06701838
- Conditions
- ACTH-Secreting Pituitary Adenoma, Adenoma, Adrenal Gland Diseases, +25 more
- Locations
-
Not specified
Enrolling by invitation
Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease
NCT07108244
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
- Locations
-
- Erasmus University Medical Centre Rotterdam, South Holland, Netherlands
- University Hospital Basel Basel, Canton of Basel-City, Switzerland
Enrolling by invitation
Combination Osilodrostat and Cabergoline in Cushing's Disease
NCT07603466
- Conditions
- 46, XX Disorders of Sex Development, Adrenal Gland Diseases, Adrenal Insufficiency, +27 more
- Locations
-
- Faiha Specialized Diabetes, Endocrine, and Metabolism Center Basra, Iraq
- Al-Hassan Metabolism Endocrine and Diabetes Center Karbala, Iraq
- Al-Waffa Specialized Center for Diabetes and Endocrinology Mosul, Iraq
- Najaf Specialized Diabetes and Endocrine Center Najaf, Iraq
Active, not recruiting
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
NCT03604198
- Conditions
- ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +30 more
- Locations
-
- Site 49 Phoenix, Arizona, United States
- Site 35 Stanford, California, United States
- Site 39 Torrance, California, United States
- Site 50 Miami, Florida, United States
Active, not recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
NCT05804669
- Conditions
- ACTH Syndrome, Ectopic, Adrenal Gland Diseases, Adrenocortical Hyperfunction, +14 more
- Locations
-
- National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
Active, not recruiting
Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms
NCT03974789
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
- Locations
-
- CHU de Nimes Nîmes, France
Active, not recruiting
Postoperative Thrombosis Prevention in Patients With CD
NCT04486859
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
- The First Affiliated Hospital of Sun Yat sen University Guangzhou, Guangdong, China
- Tongji Hospital Wuhan, Hubei, China
- Huashan Hospital Shanghai, Shanghai Municipality, China